Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-01-21 RUBINSTEIN JULIE President Sale −6,444 $66.15 $426K 8,556
2021-01-21 RUBINSTEIN JULIE President Sale −8,511 $66.87 $569K 45
2021-01-21 RUBINSTEIN JULIE President Sale −45 $67.63 $3K 0
2021-01-21 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 185,000
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Option exercise +50,000 $6.55 $328K 50,679
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Sale −20,394 $66.84 $1.4M 30,285
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Sale −24,945 $67.39 $1.7M 5,340
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Sale −4,661 $68.20 $318K 679
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −50,000 300,000
2021-01-20 Cohen Chad M Chief Financial Officer Option exercise +50,000 $6.32 $316K 51,000
2021-01-20 Cohen Chad M Chief Financial Officer Sale −11,050 $66.82 $738K 39,950
2021-01-20 Cohen Chad M Chief Financial Officer Sale −33,938 $67.35 $2.3M 6,012
2021-01-20 Cohen Chad M Chief Financial Officer Sale −5,012 $68.33 $342K 1,000
2021-01-20 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −50,000 265,000
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Option exercise +50,000 $6.32 $316K 50,679
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Sale −20,394 $66.84 $1.4M 30,285
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Sale −24,945 $67.39 $1.7M 5,340
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Sale −4,661 $68.20 $318K 679
2021-01-20 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −50,000 133,700
2021-01-20 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000

Page 69 of 120 · 2,386 trades